» Articles » PMID: 37184826

Major Adverse Cardiovascular Events Among Obese Patients with Diabetes After Metabolic and Bariatric Surgery: a Meta-analysis of Matched Cohort and Prospective Controlled Studies with 122,361 Participates

Overview
Journal Obes Surg
Date 2023 May 15
PMID 37184826
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Metabolic and bariatric surgery (MBS) can exert effective function on glycemic control. The present study aimed to estimate the risk of MACE among obese patients with diabetes after MBS.

Materials And Methods: Systematic search of PubMed, Embase, Medline, and Web of Science was performed for studies published before 20th February 2023. The odds ratio (OR) corresponding to the 95% confidence interval (95% CI) was used to assess the outcome. The statistical heterogeneity among studies was assessed with the Q-test and I statistics.

Results: Fifteen cohort studies with 122,361 obese patients with diabetes were available for analysis. Our meta-analysis found significantly decreased morbidity and mortality of MACE (OR = 0.65, 95% CI = 0.59-0.72, I = 62.8% for morbidity, OR = 0.49, 95% CI = 0.36-0.67, I = 68.7% for mortality). Subgroup analysis revealed MBS decreased cerebrovascular disease, coronary artery disease, atrial fibrillation, heart failure, myocardial infarction, and stroke risk.

Conclusion: Our meta-analysis indicated that MBS for obese patients with diabetes is beneficial to decreasing MACE risk. Moreover, further studies estimating the functional effect may eventually provide a better and comprehensive understanding of the effect on different populations.

Citing Articles

Five-Year Outcomes of Bariatric Surgery vs. Conservative Weight Management in People with HIV: A Single-Center Tertiary Care Experience.

Fehervari M, Mitra A, Sargsyan N, Davison N, Turner M, Efthimiou E Obes Surg. 2024; 34(10):3594-3605.

PMID: 39191979 PMC: 11481672. DOI: 10.1007/s11695-024-07443-7.


Analysis Using Various Models on the Effect of Metabolic Surgery on Cardiovascular Disease Risk in the Chinese Population with Obesity.

Wang Z, Xu G, Chen G, Amin B, Wang L, Li Z Diabetes Metab Syndr Obes. 2024; 17:2457-2468.

PMID: 38910913 PMC: 11192193. DOI: 10.2147/DMSO.S436176.


Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes.

Zhu J, Wilding J Curr Atheroscler Rep. 2023; 26(1):1-10.

PMID: 38148417 PMC: 10776473. DOI: 10.1007/s11883-023-01181-4.

References
1.
Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

2.
Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

3.
Afshin A, Forouzanfar M, Reitsma M, Sur P, Estep K, Lee A . Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017; 377(1):13-27. PMC: 5477817. DOI: 10.1056/NEJMoa1614362. View

4.
Kahn S, Hull R, Utzschneider K . Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121):840-6. DOI: 10.1038/nature05482. View

5.
Sandouk Z, Lansang M . Diabetes with obesity--Is there an ideal diet?. Cleve Clin J Med. 2017; 84(7 Suppl 1):S4-S14. DOI: 10.3949/ccjm.84.s1.02. View